Table 1. Summary of human pancreas samples from VA medical center used in immunohistochemical analysis of Sema3E expression.
| Type of sample | # of cases(% of total) | Total # of cases (% of grand total) | |
|---|---|---|---|
| Neoplasm | 44 | ||
| Malignant | 33 (75%) | ||
| Adenocarcinoma | 25 (76%) | ||
| Sarcomatoid carcinoma | 1 (3%) | ||
| Neuroendocrine carcinoma | 7 (21%) | ||
| Uncertain | 8 (18%) | ||
| Intraductal papillary mucinous neoplasm | 2 (25%) | ||
| Neuroendocrine tumor | 6 (75%) | ||
| Benign | 3 (7%) | ||
| Pancreatic intraepithelial neoplasm | 1 (33%) | ||
| Serous microcystic adenoma | 2 (67%) | ||
| Non-neoplasm | 5 | ||
| Fibrosis | 1 (20%) | ||
| Acute pancreatitis | 1 (20%) | ||
| Islet hyperplasia | 2 (40%) | ||
| Lymphoepithelial cyst | 1 (20%) | ||
| Normal | 5 | ||
| Associated adenocarcinoma | 2 (40%) | ||
| Associated neuroendocrine carcinoma | 1 (20%) | ||
| Associated neuroendocrine tumor | 2 (40%) |